191 related articles for article (PubMed ID: 15112273)
1. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence.
Tai AL; Yan WS; Fang Y; Xie D; Sham JS; Guan XY
Cancer; 2004 May; 100(9):1918-27. PubMed ID: 15112273
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.
Danner BC; Hellms T; Jung K; Gunawan B; Didilis V; Füzesi L; Schöndube FA
Ann Thorac Surg; 2011 Sep; 92(3):1038-43. PubMed ID: 21871296
[TBL] [Abstract][Full Text] [Related]
3. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma.
Björkqvist AM; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Tammilehto L; Mattson K; Vainio H; Knuutila S
Genes Chromosomes Cancer; 1998 May; 22(1):79-82. PubMed ID: 9591638
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.
Pei J; Balsara BR; Li W; Litwin S; Gabrielson E; Feder M; Jen J; Testa JR
Genes Chromosomes Cancer; 2001 Jul; 31(3):282-7. PubMed ID: 11391799
[TBL] [Abstract][Full Text] [Related]
5. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
6. [Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking].
Yan WS; Song LY; Wei WD; Li A; Liang QW; Liu JH; Fang Y
Ai Zheng; 2005 Jan; 24(1):47-52. PubMed ID: 15642199
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
8. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
[TBL] [Abstract][Full Text] [Related]
9. Assessment of molecular events in squamous and non-squamous cell lung carcinoma.
Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L
Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in Korean nonsmall cell lung carcinomas: degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies.
Park SY; Kim YH; In KH; Chun YH; Park SH
Cancer Genet Cytogenet; 2004 Jul; 152(2):153-7. PubMed ID: 15262437
[TBL] [Abstract][Full Text] [Related]
11. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
[TBL] [Abstract][Full Text] [Related]
12. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
Visbal AL; Williams BA; Nichols FC; Marks RS; Jett JR; Aubry MC; Edell ES; Wampfler JA; Molina JR; Yang P
Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
[TBL] [Abstract][Full Text] [Related]
15. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a human non-small cell lung cancer cell line.
Tai AL; Fang Y; Sham JS; Deng W; Hu L; Xie D; Tsao GS; Cheung AL; Guan XY
Oncol Rep; 2005 Jun; 13(6):1029-32. PubMed ID: 15870917
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers.
Wong MP; Fung LF; Wang E; Chow WS; Chiu SW; Lam WK; Ho KK; Ma ES; Wan TS; Chung LP
Cancer; 2003 Mar; 97(5):1263-70. PubMed ID: 12599234
[TBL] [Abstract][Full Text] [Related]
19. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
20. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
Suzuki M; Shigematsu H; Iizasa T; Hiroshima K; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
Cancer; 2006 May; 106(10):2200-7. PubMed ID: 16598760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]